FRAMESHIFT
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99089643
- Mark type
- Stylized text
- Filed
- 18 Mar 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Jennifer A. Visintine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of retinal vasculopathy with cerebral leukoencephalopathy, cancer, and autoimmune diseases
- Class 042 — Scientific and technological services: Research and development of new products, pharmaceutical preparations, and medical devices; scientific, medical, and pharmaceutical research and development; drug discovery services; providing medical and scientific research information in the field of medicine, medical devices, and pharmaceuticals; scientific investigations for medical purposes; conducting research and clinical trials for others in the field of medicine, medical devices, and pharmaceuticals
Owner
- Frameshift Bio, Inc., Chicago, IL, US
- Frameshift Bio, Inc., Chicago, IL, US
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Aug 2025 — ASSIGNED TO EXAMINER
- 10 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Mar 2025 — NEW APPLICATION ENTERED